rs56017519
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PP3
The NM_000441.2(SLC26A4):c.1730T>C(p.Val577Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00000435 in 1,607,936 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000441.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC26A4 | ENST00000644269.2 | c.1730T>C | p.Val577Ala | missense_variant | Exon 16 of 21 | NM_000441.2 | ENSP00000494017.1 | |||
SLC26A4 | ENST00000480841.5 | n.579T>C | non_coding_transcript_exon_variant | Exon 7 of 8 | 3 | |||||
SLC26A4 | ENST00000644846.1 | n.440T>C | non_coding_transcript_exon_variant | Exon 6 of 10 | ENSP00000494344.1 | |||||
SLC26A4 | ENST00000492030.2 | n.91-704T>C | intron_variant | Intron 1 of 5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152056Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251110Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135692
GnomAD4 exome AF: 0.00000412 AC: 6AN: 1455880Hom.: 0 Cov.: 28 AF XY: 0.00000276 AC XY: 2AN XY: 724738
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152056Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74252
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: SLC26A4 c.1730T>C (p.Val577Ala) results in a non-conservative amino acid change located in the STAS domain of the encoded protein sequence. Four of four in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251110 control chromosomes. c.1730T>C has been reported in the literature in individuals affected with suspected Pendred Syndrome and hearing loss (Tesolin_2021, Roesch_2018, Likar_2018). These reports do not provide unequivocal conclusions about association of the variant with Pendred Syndrome. A functional study with variant-transfected cells showed severe loss in ion transport function, complete retention in the ER and dramatic reduction of expression (Roesch_2018). The following publications have been ascertained in the context of this evaluation (PMID: 29293505, 29320412, 34680964). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
Pendred syndrome Uncertain:1
- -
not provided Uncertain:1
- -
Autosomal recessive nonsyndromic hearing loss 4 Uncertain:1
- -
Hearing impairment Uncertain:1
- -
SLC26A4-related disorder Uncertain:1
The SLC26A4 c.1730T>C variant is predicted to result in the amino acid substitution p.Val577Ala. This variant was reported alone or together with additional one or two variants in SLC26A4 in individuals with non-syndromic hearing loss (Table 2,3, Likar et al. 2018. PubMed ID: 29293505; Roesch et al. 2018. PubMed ID: 29320412; Tesolin et al. 2021. PubMed ID: 34680964). In vitro functional studies show significant protein function reduction compared to wild type (76% reduction) (Table 3, Roesch et al. 2018. PubMed ID: 29320412). This variant is reported in 0.00088% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Although we suspect that this variant is pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at